You are here

Comment

Discuss

What’s the Stem Cells Buzz this Week? - Cancer Immunotherapy, Cellular Conspiracy of ALS, Vav1-null HSPCs, and Leukemic BM Niche Adaptation!

The Stem Cells Portal brings you a roundup of some of the new and exciting stories in the ever-changing world of stem cells, regenerative medicine, and beyond!

Researchers track dynamics behind why stem cells respond differently to injury and aging

A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP), La Jolla, California, describes the biology behind why muscle stem cells respond differently to aging or injury. The findings have important implications for therapeutic strategies to regenerate skeletal muscle in response to the normal wear and tear of aging, or in cases of injury or muscle diseases such as muscular dystrophy.

Study prompts new ideas on cancers’ origins

Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer — a finding that could upend the way scientists think about the origins of the disease.

Therapy that modifies patients’ own blood cells to fight advanced cancers being tested

Scientists have taken a step forward in efforts to harness patients’ own white blood cells to fight deadly cancers. A pilot study, funded by Montefiore Einstein Center for Cancer Care, in partnership with New York Blood Center (NYBC), has demonstrated that white blood cells can be removed, genetically modified and reinserted into cancer patients.

This holds potential to fight cancers that standard therapy has failed to treat. The next step is to duplicate this finding in multiple patients. 

New Model Highlights a Mature Cell of Origin for Melanoma

A new study suggests that dedifferentiated mature melanocytes represent the cell of origin for melanoma, and not stem cells as previously thought

Exploring how Insulin Affects Neural Stem Cells: An New role for Cdk4!

A new study indicates that insulin controls adult neural stem cell proliferation and differentiation via the activities of cyclin-dependent kinase 4

What’s the Stem Cells Buzz this Week? - iPSC Secretome, Stem Cell‐Derived Retina, Rejuvenating old HSCs, and Skeletal Muscle Stem Cells!

The Stem Cells Portal brings you a roundup of some of the new and exciting stories in the ever-changing world of stem cells, regenerative medicine, and beyond!

What’s the Stem Cells Buzz this Week? - Induced Mesenchymal Progenitor Cells, MSC Treatment for DRE, iPSC-derived Corneal Epithelial Cells, and Stem Cell Therapy for CLI!

The Stem Cells Portal brings you a roundup of some of the new and exciting stories in the ever-changing world of stem cells, regenerative medicine, and beyond!

Rapamycin prevents age-related loss of stem cells

Adult stem cells replenish dying cells and regenerate damaged tissues throughout our lifetime. We lose many of those stem cells, along with their regenerative capacity, as we age. Working in flies and mice, researchers at the Buck Institute and elsewhere discovered that TOR, a nutrient-sensing pathway which is central to the aging process, drives the loss of adult stem cells.

Treating mice with the TOR-inhibitor rapamycin prevented this loss and could reverse age-related loss of stem cells in mouse trachea. The research is published in Cell Stem Cell.

A common virus may help inform treatment planning for stem cell transplant patients

Most healthy people barely notice infection with the human cytomegalovirus (hCMV), a form of the herpes virus that has evolved with humans over thousands of years and usually lays dormant in the body after initial infection.

Pages

Subscribe to Stem Cells Portal - Stem Cells Journal Online Community RSS